Sarepta's eteplirsen for the treatment of Duchenne muscular dystrophy in patients who have a confirmed mutation of the DMD gene that is amenable to exon 51 skipping
Read MoreAPR 25 PCNS
Sarepta's eteplirsen for the treatment of Duchenne muscular dystrophy in patients who have a confirmed mutation of the DMD gene that is amenable to exon 51 skipping
Read MoreJAN 22 PCNS
Sarepta Therapeutics' eteplirsen for Duchenne muscular dystrophy
Read MoreJAN 22 PCNS
Sarepta Therapeutics' eteplirsen for Duchenne muscular dystrophy
Read MoreNOV 24 PCNS
BioMarin Pharmaceutical's drisapersen for Duchenne muscular dystrophy
Read MoreNOV 24 PCNS
BioMarin Pharmaceutical's drisapersen for Duchenne muscular dystrophy
Read MoreNOV 24 PCNS BA
BioMarin Pharmaceutical's drisapersen for Duchenne muscular dystrophy
Read More